Jagsonpal Pharmaceuticals is set to initiate its first share buyback plan worth ₹1,100 crore, enhancing investor confidence and reflecting financial strength.
Bitcoin holdings are sliding as centralized exchange reserves hit alarming lows, reflecting potential shifts in market dynamics and investor strategies.